Examiner Christopher Reyes

Appears inactive Last observed office action: November 2014 (136 months ago).

Examiner Christopher Reyes appears to be about average relative to their peer examiners. Their lifetime grant ratio is 12.1%, they average 1.50 office actions per granted patent, and their rejection profile is dominated by §103.

Difficulty vs AU About Average

Difficulty vs Group About Average

Difficulty vs TC About Average

Difficulty vs USPTO About Average

Average OA / Grant 1.50

Export

Word PDF

Create account to export.

Examiner Details

Observed Examiner Years: 3 years (2012-2014)
Tech Center: 1600 - Biotechnology and Organic
Group: 1630 - Stem Cells and Nucleic Acid Related Therapy

Metrics

Applications Evaluated: 33
Granted Applications: 4
Non-Granted Applications: 29
Avg OA / Grant: 1.50
Last OA Observed: November 2014 (136 months ago)
Art Units Seen: 1639
Work Groups Seen: 1630 - Stem Cells and Nucleic Acid Related Therapy

Context Comparison

Scope	Examiners	Lifetime Grant Ratio	Avg OA / Grant
This Examiner	1	12.1%	1.50
Art Unit	18	45.5%	2.16
Group	243	38.4%	2.18
Tech Center	1,349	39.5%	2.02
USPTO	16,116	54.8%	1.98

Grant Timeline

Shaded region marks the last two observed years, where grant outcomes may lag due to recency.

Year	Applications	Granted	Grant Rate
No observed data before 2012; examiner may not yet have been active in the available dataset.
2012	8	1	12.5%
2013	11	2	18.2%
2014	14	1	7.1%
No observed data after 2014; examiner may have gone inactive or moved out of examining work.

4 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA #	Office Actions	§ 101 Percentage	§ 102 Percentage	§ 103 Percentage	§ 112 Percentage
1	33	3.0%	9.1%	66.7%	6.1%
2	21	0.0%	0.0%	76.2%	9.5%
3	8	0.0%	0.0%	100.0%	0.0%
4	2	0.0%	0.0%	100.0%	0.0%

§ 101 Yearly Trend

0.0%

2009

0.0%

2010

0.0%

2011

6.3%

2012

0.0%

2013

0.0%

2014

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.